Skip to main content

Table 2 Cardiac parameters of the study population subdivided according to the presence or the absence of Metabolic syndrome and Hyperhomocysteinemia

From: Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese

 

MetS (−)

MetS (+)

HHcy (−)

HHcy (+)

HHcy (−)

HHcy (+)

End-diastolic LV internal dimension(mm)

4.61 ± 0.41

4.74 ± 0.43*

4.72 ± 0.42*

4.85 ± 0.44*#^

End-diastolic posterior wall thickness(mm)

0.83 ± 0.08

0.86 ± 0.11*

0.88 ± 0.12*#

0.90 ± 0.11*#^

End-diastolic interventricular septum(mm)

0.85 ± 0.11

0.89 ± 0.15*

0.90 ± 0.12*#

0.94 ± 0.14*#^

LV mass(g)

144.60 ± 38.59

162.44 ± 47.21*

165.74 ± 47.11*#

181.69 ± 50.27*#^

LV mass indexed for BSA(gm−2)

90.93 ± 22.27

99.19 ± 26.93*

98.77 ± 26.92*

105.01 ± 28.06*#^

LV mass indexed for height2.7(gm-2.7)

40.96 ± 10.93

43.78 ± 13.10*

47.96 ± 13.94*#

49.77 ± 14.21*#^

Ejection fraction

63.39 ± 3.98

62.667 ± 4.21*

63.16 ± 3.91#

62.54 ± 4.42*^

  1. Abbreviations: LV left ventricular, MetS metabolic syndrome. * vs. MetS (−) + HHcy (−), P < 0.05; # vs. MetS (−) + HHcy (+), P < 0.05; ^ vs. MetS (+) + HHcy (−), P < 0.05;